Season 2 · Episode 3
3: Lundbeck ready to make acquisitions
Dealcast: The M&A Podcast · Anthony Phillips
February 28, 20197m 45s
Audio is streamed directly from the publisher (podcast.wistia.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Danish pharmaceutical company Lundbeck [CPH: LUN] is poised for a run of M&A to replenish its drug pipeline. We caught up with our Nordics reporter, Karoliina Liimatainen, who spoke recently with the company's chief executive, Deborah Dunsire, and has more on the company's plans for growth.